Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

After menopause, do adrenal and residual ovarian stromal androgens contribute more to testosterone availability?

After menopause, adrenal precursors and residual ovarian stromal tissue become major contributors to circulating testosterone availability.

PlausibleAugust 5, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

after menopause, adrenal and residual ovarian-stromal androgen production become more important contributors to testosterone availability

laying out figure…
2 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a postmenopausal endocrine shift away from follicular ovarian hormone production toward other androgen sources. The mechanism framing indicates that higher LH levels help sustain residual ovarian stromal androgen synthesis, while adrenal precursors are converted peripherally to support the remaining testosterone pool.

Verified conclusion

Following menopause, follicular depletion halts ovarian estrogen production, and overall circulating androgen pools decline by approximately 50%. Consequently, the body undergoes a significant endocrine shift, relying on alternative pathways to maintain systemic testosterone availability.

Clinical evidence and quantitative contributions

  • Direct ovarian secretion: The postmenopausal ovary is not hormonally inert; its residual stromal tissue continues to synthesize and directly secrete testosterone and androstenedione, accounting for approximately 40% to 50% of circulating testosterone.
  • Impact of oophorectomy: The clinical significance of this residual function is demonstrated by surgical studies showing that postmenopausal women who undergo bilateral oophorectomy experience a rapid, permanent 30% to 50% reduction in circulating testosterone levels compared to naturally postmenopausal counterparts with intact ovaries.

Mechanistic pathways and adrenal conversion

  • Adrenal precursor conversion: The adrenal zona reticularis secretes primary androgenic precursors, specifically dehydroepiandrosterone (DHEA), DHEA-S, and androstenedione. These precursors are subsequently converted in peripheral tissues, such as adipose tissue and skin, to supply the remaining half of circulating active testosterone.
  • Gonadotropin stimulation: Mechanistically, the loss of follicular negative feedback in the postmenopausal state leads to elevated luteinizing hormone (LH) levels. This elevated LH directly stimulates specialized residual ovarian-stromal, hilar, and theca-like cells to maintain direct testosterone and androstenedione synthesis.

Bottom line

  • Postmenopausal testosterone availability is maintained by a dual system where the LH-stimulated residual ovarian stroma directly secretes 30% to 50% of the circulating pool, while peripheral conversion of adrenal precursors (DHEA, DHEA-S, androstenedione) supplies the remaining half.

References

  1. The hormonal activity of the postmenopausal ovary - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  2. Prescribing Testosterone and DHEA: The Role of Androgens ... — consultqd.clevelandclinic.org ↗
  3. The Roles of Androgens in Humans: Biology, Metabolic ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  4. Testosterone insufficiency in women: fact or fiction? — bumc.bu.edu ↗
  5. Stromal Cells of the Human Postmenopausal Ovary Display a ... — academic.oup.com ↗
  6. [Ovarian androgenesis in women after menopause] - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  7. Do Ovaries Still Produce Hormones After Menopause? — scienceinsights.org ↗
  8. pm 3 2006.qxp — termedia.pl ↗
  9. Ovarian androgen production in postmenopausal women — pubmed.ncbi.nlm.nih.gov ↗
  10. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  11. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  12. Ovarian Androgen Production in Postmenopausal Women — academic.oup.com ↗
  13. Effect of Bilateral Oophorectomy on Women's Long-Term Health - William H Parker, Vanessa Jacoby, Donna Shoupe, Walter Rocca, 2009 — journals.sagepub.com ↗
  14. Approach to Investigation of Hyperandrogenism in a ... — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→